Dry Powders for Pulmonary Delivery: Device and Formulation Technologies for an Enhanced Lung Deposition, 2nd Edition
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmaceutical Technology, Manufacturing and Devices".
Deadline for manuscript submissions: 30 August 2024 | Viewed by 102
Special Issue Editor
Interests: drug delivery to the lung; formulations for dry powder inhalers; formulations for nebulisers; nanosuspension for inhaled
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Inhalation aerosol therapy is receiving a lot of interest among researchers as it is the preferred administration route when delivering medication to manage airway diseases and, more recently, systemic diseases.
Lung deposition and, hence, the therapeutic efficiency of DPI depend on several factors, including the formulations, device, and patient inhalation technique. Therefore, it is essential to consider the design of the inhaler device alongside its specific formulation to ensure an enhanced lung deposition and to give the patient the opportunity to achieve maximum therapeutic benefit. Despite advances in current DPI research, there is still a significant gap that needs addressing to understand the relationship of different parameters in the formulation and inhaler device design in enhancing lung deposition and lung bioavailability.
This Special Issue aims to collect the latest advances and state-of-the-art developments in the field of DPI device design, including smart inhalers, contribution of different formulation parameters such as surface energy, cohesion, and adhesion forces and particle engineering technology on lung deposition.
Dr. Khaled Assi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanodrug delivery system
- particle engineering technology
- device development, including smart inhalers
- dissolution
- pharmacokinetics and lung bioavailability of inhaled drugs
- compliance and inhaler technique
